A Phase I/IIa Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
Phase of Trial: Phase I/II
Latest Information Update: 02 Aug 2016
At a glance
- Drugs Gastric cancer vaccine (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Mar 2016 Status changed from recruiting to completed, as reported by OncoTherapy Science media release.
- 07 Aug 2015 Planned End Date changed from 1 Nov 2014 to 1 Jun 2016, as reported by ClinicalTrials.gov.
- 07 Aug 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Nov 2015, as reported by ClinicalTrials.gov.